Walking Impairment in Multiple Sclerosis Market to Grow at a CAGR of 6.8%

Pune, India - Exactitude Consultancy: The global Walking Impairment in Multiple Sclerosis (MS) Market is projected to grow at a CAGR of 6.8% over the forecast period. Rising MS prevalence, growing focus on improving mobility outcomes, expanded access to disease-modifying therapies (DMTs), and the introduction of advanced symptomatic treatments are key factors driving market growth.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72121

Introduction
Walking impairment is one of the most common and debilitating symptoms of multiple sclerosis, affecting a majority of patients during the disease course. Impaired mobility significantly impacts daily functioning, quality of life, independence, and long-term healthcare needs. The market includes pharmacological therapies, assistive devices, rehabilitation solutions, wearable mobility trackers, and digital gait assessment systems.

Growing awareness of early symptom management, increasing uptake of mobility-enhancing drugs, and expanding neurorehabilitation services are accelerating global demand.

Key Takeaways
• Global Walking Impairment in MS Market expected to grow at a CAGR of 6.8% during the forecast period.
• Rising MS prevalence in North America and Europe continues to drive mobility-focused treatment adoption.
• Significant progress in digital gait analysis, wearable rehabilitation devices, and AI-driven mobility monitoring.
• Symptomatic drugs such as fampridine (dalfampridine) remain widely used for improving walking speed.
• Major players include Biogen, Novartis, Sanofi, Teva, Acorda Therapeutics, Medtronic, Ottobock, and Ekso Bionics.

Market Drivers
• Rising global MS patient pool: Increasing diagnosis rates and better access to neurologic care.
• High prevalence of mobility-related symptoms: Walking impairment affects over 80% of MS patients at some stage.
• Introduction of mobility-enhancing therapies: Drug innovations and optimized rehabilitation protocols.
• Growth of digital mobility assessment tools: Wearables and AI analytics improving clinical decision-making.
• Expanding neurorehabilitation centers: Specialized gait clinics and physiotherapy services boosting adoption.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72121/walking-impairment-in-multiple-sclerosis-market

Market Segmentation
By Treatment Type
• Pharmacological Therapies
o Fampridine/Dalfampridine
o Muscle Relaxants
o Spasticity Management Drugs

• Rehabilitation Therapies
o Physiotherapy
o Gait Training
o Functional Electrical Stimulation (FES)

• Assistive Mobility Devices
o Walkers & Canes
o Orthotic Devices
o Exoskeletons
o Wheelchairs

• Digital & Wearable Solutions
o Gait Assessment Tools
o Activity Trackers
o AI-based Mobility Monitoring Systems

By End User
• Hospitals & Neurology Centers
• Rehabilitation & Physiotherapy Clinics
• Home Care Settings
• Sports & Gait Laboratories

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72121

Regional Outlook
North America
Holds the largest share due to high MS prevalence, strong adoption of symptomatic mobility therapies, advanced rehabilitation centers, and availability of innovative digital tools.

Europe
Shows strong growth supported by national MS registries, structured treatment pathways, and widespread use of gait rehabilitation programs.

Asia-Pacific
Fastest-growing region due to improving MS awareness, expanding neurology care infrastructure, and increasing adoption of assistive mobility devices.

Latin America & Middle East/Africa
Gradual adoption as access to MS treatment improves, though cost constraints and limited rehabilitation resources remain challenges.

Recent Developments
• Launch of AI-powered gait analysis platforms to quantify mobility deterioration in MS patients.
• Expansion of robotic exoskeleton technology to support improved walking ability.
• Clinical trials evaluating new symptomatic mobility treatments beyond traditional potassium channel blockers.
• Integration of wearable mobility sensors into MS patient monitoring programs.
• Partnerships between pharma companies and rehabilitation centers to enhance mobility outcomes.

Expert Quote
"Walking impairment is one of the most challenging aspects of MS management. With advancements in digital mobility tools, symptomatic therapies, and rehabilitation technologies, patient outcomes are improving globally,"
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy

Future Outlook
The Walking Impairment in MS Market is expected to grow steadily as healthcare providers prioritize early mobility intervention, digital gait assessment becomes more mainstream, and new therapies aimed at improving neurological function emerge. Rehabilitation technologies-especially wearable and robotic systems-will be key in shaping future market dynamics.

This report is also available in the following languages : Japanese (多発性硬化症市場における歩行障害), Korean (다발성 경화증 시장의 보행 장애), Chinese (多发性硬化症步行障碍市场), French (Le marché des troubles de la marche chez les personnes atteintes de sclérose en plaques), German (Markt für Gehbehinderungen bei Multipler Sklerose), and Italian (Mercato della disabilità motoria nella sclerosi multipla), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72121

Our More Reports:

Diabetic Neuropathic Pain (DNP) Market
https://exactitudeconsultancy.com/reports/71986/diabetic-neuropathic-pain-dnp-market

Familial Hypercholesterolemia Market
https://exactitudeconsultancy.com/reports/72016/familial-hypercholesterolemia-type-ii-hyperlipoproteinemia-market

Gaucher's Disease Market
https://exactitudeconsultancy.com/reports/71990/gaucher-s-disease-market

Hypercholesterolemia Market
https://exactitudeconsultancy.com/reports/71992/hypercholesterolemia-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.